Neurocognitive Outcomes Following Perinatal Human Immunodeficiency Virus Infection

Area of Science:

• Pediatric infectious diseases
• Neuroscience
• Public health

Background:

• Perinatal human immunodeficiency virus (HIV) infection can significantly impact neurodevelopment and long-term cognitive and behavioral outcomes in children.
• Antiretroviral therapy (ART) is a cornerstone in managing HIV, with early and consistent viral suppression being a key goal.

Purpose of the Study:

• To highlight the importance of early, consistent viral suppression through ART for protecting neurodevelopment in perinatally HIV-infected children.
• To emphasize the need for comprehensive monitoring and support systems to optimize health and well-being.

Main Methods:

• This is a review and synthesis of current knowledge regarding neurodevelopmental outcomes in perinatally HIV-infected children.
• Focus is placed on the role of antiretroviral therapy and supportive care strategies.

Main Results:

• Early and consistent viral suppression via ART is critical for mitigating negative neurodevelopmental effects.
• Comprehensive monitoring, including neurodevelopmental assessments, cognitive functioning evaluations, and mental health screening, is essential.
• Addressing socioeconomic and environmental risks, alongside caregiver support, significantly contributes to improved outcomes.

Conclusions:

• Optimizing neurodevelopmental and long-term cognitive/behavioral outcomes in perinatally HIV-infected children requires a multi-faceted approach.
• Sustained viral suppression through adherence to ART, coupled with robust monitoring and supportive interventions, is paramount for achieving the best possible health and well-being.